■In vitro and in vivo inflammatory response suppression of alveolar epithelial cells via reduction in the TLR4/NF-κB/NLRP3 inflammasome pathway [45];■Improved clinical score of adult CF patients [54]. This evidence concerns the gene NFKB1 and cystic fibrosis.